MetaCensus is built to support the exchange and review of data by various stakeholders and performs multicriteria decision analysis (MCDA) to assess and account for varying perspectives, counterpoints, and biases.
MetaCensus is the first open-access data repository built for peer-review and meta-analysis. The tool aims to break down stakeholder silos to quickly achieve scientific consensus.
A better estimate of menopausal status will help providers and patients address both the symptoms of menopause and the associated risks, such as cardiovascular disease and osteoporosis.
The MenoCheck test helps providers treat women who are experiencing menopausal transition and manage the health risks associated with decreased estrogen production.
ARUP’s new lupus anticoagulant panel neutralizes several interfering anticoagulants to limit their impact on test results and reduce the likelihood of false-negative and false-positive results.
ARUP medical directors and scientists, including (from left to right) Sherin Shaaban, MD, PhD, FACMG; Yuan Ji, PhD, MBA, DABCP, FACMG; and Hunter Best, PhD, FACMG, along with others, will present their latest research and share insights for current and future geneticists at the Annual Clinical Genetics Meeting in March.
ARUP medical directors and scientists will discuss the latest in pharmacogenomics, RNA sequencing, and laboratory genetics career pathways at the upcoming ACMG Annual Clinical Genetics Meeting.
ARUP medical directors and scientists advanced laboratory medicine and improved patient care with publication of more than 130 peer-reviewed articles in fiscal year 2023.
Researchers at ARUP Laboratories published more than 130 peer-reviewed articles and contributed more than 135 posters or presentations at medical conferences in FY2023 to advance laboratory medicine.
Four different algorithms to lead clinicians through the correct approach to thyroid testing are available on arupconsult.com.
Lab testing is key to thyroid disease diagnosis and proper treatment but can be challenging. ARUP Consult’s thyroid disease testing resources are divided into easy-to-navigate topics and algorithms.
Dipanwita Banerjee, MS, joined ARUP in 2019 to follow her desired career path after more than 10 years away from the laboratory.
After wrapping up her education in plant biology, Dipanwita Banerjee, MS, took some time off to see the world and start a family. She later returned to the laboratory environment at ARUP.
As part of an ongoing recruitment fraud scheme, scammers posing as ARUP recruiters are targeting jobseekers on LinkedIn.
Scammers posing as ARUP recruiters on LinkedIn have attempted to collect sensitive information from jobseekers. ARUP recommends that potential applicants approach job offers with caution.
Melanie Mallory, MS, lead bioinformatics scientist at ARUP Laboratories, played a key role in the development and validation of ARUP’s Cytomegalovirus Drug Resistance by Next Generation Sequencing assay.
Next generation sequencing provides a more rigorous and sensitive method to identify drug-resistant variants of cytomegalovirus, which enables earlier detection and more effective treatment.
From left to right: Nermin Uvejzovik, Staci Beck, Aubrie Smith, Mitzi Irish, Carrie Pederson, and Derek Gleue accept their third place award in the annual Pipetting Challenge. Not pictured: Sheri Mitchell, Wendy Dong, Cindy Kuo, and Kris Moore.
More than 250 ARUP employees participated in Advanced Instruments’ Pipetting Challenge this year. Seven ARUP teams finished in the top 10 in the nationwide competition.
Madhu Menon, MD, PhD, FCAP, ARUP’s section chief of Hematopathology, works with a team of experts to deliver accurate and timely results.
PhD scientists, analysts, and medical directors within ARUP’s Hematopathology department meet often to ensure clinicians and patients receive a diagnosis that reflects an integrated approach.
Jonathan Genzen, MD, PhD (left), chief medical officer and senior director of governmental affairs, and Jonathan Carr, JD (right), compliance officer, prepare for ARUP’s webinar on the FDA’s proposed rule to regulate lab-developed tests.
Days before the public comment period ends, ARUP Laboratories’ experts host webinar to educate and encourage attendees to provide comments on the FDA’s proposed rule to regulate lab-developed tests.